Yasons Chemex Care Ltd
Incorporated in 2017, Yasons Chemex Care Ltd is in the business of Trading of chemicals and manufacturing of dyes and inter mediates and FMCG Products[1]
- Market Cap ₹ 19.5 Cr.
- Current Price ₹ 10.1
- High / Low ₹ 14.0 / 8.55
- Stock P/E 20.7
- Book Value ₹ 21.5
- Dividend Yield 0.00 %
- ROCE 5.26 %
- ROE 2.29 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.47 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 3.44% over last 3 years.
- Earnings include an other income of Rs.3.77 Cr.
- Company has high debtors of 158 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Dyes And Pigments
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 36.77 | 36.77 | 69.24 | 76.53 | 96.82 | |
| 36.28 | 36.28 | 66.64 | 75.26 | 97.41 | |
| Operating Profit | 0.49 | 0.49 | 2.60 | 1.27 | -0.59 |
| OPM % | 1.33% | 1.33% | 3.76% | 1.66% | -0.61% |
| 4.23 | 4.23 | 0.96 | 2.78 | 3.77 | |
| Interest | 0.41 | 0.41 | 1.33 | 1.44 | 1.28 |
| Depreciation | 0.10 | 0.10 | 0.43 | 0.38 | 0.37 |
| Profit before tax | 4.21 | 4.21 | 1.80 | 2.23 | 1.53 |
| Tax % | 18.76% | 18.76% | 30.56% | 27.35% | 38.56% |
| 3.43 | 3.43 | 1.25 | 1.62 | 0.94 | |
| EPS in Rs | 5.81 | 2.42 | 0.65 | 0.84 | 0.49 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 38% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -35% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 3% |
| Last Year: | 2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 14.16 | 19.30 | 19.30 | 19.30 | |
| Reserves | 6.56 | 19.77 | 21.38 | 22.26 | |
| 3.47 | 8.52 | 11.16 | 13.37 | ||
| 3.40 | 7.00 | 7.49 | 13.00 | ||
| Total Liabilities | 27.59 | 54.59 | 59.33 | 67.93 | |
| 0.52 | 3.15 | 2.84 | 2.72 | ||
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | |
| Investments | 6.59 | 0.00 | 0.00 | 0.00 | |
| 20.48 | 51.44 | 56.49 | 65.21 | ||
| Total Assets | 27.59 | 54.59 | 59.33 | 67.93 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| -0.27 | -16.22 | -2.45 | -0.74 | ||
| 0.06 | 0.00 | -0.01 | -0.26 | ||
| 0.24 | 17.60 | 1.22 | 0.93 | ||
| Net Cash Flow | 0.03 | 1.38 | -1.23 | -0.07 | |
| Free Cash Flow | -0.27 | -16.24 | -2.51 | -0.98 | |
| CFO/OP | 59% | -599% | -136% | -10% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 113.06 | 151.29 | 143.75 | 157.96 | |
| Inventory Days | 82.74 | 83.94 | 96.36 | 80.86 | |
| Days Payable | 30.01 | 26.48 | 24.09 | 39.54 | |
| Cash Conversion Cycle | 165.79 | 208.75 | 216.02 | 199.28 | |
| Working Capital Days | 139.77 | 181.71 | 173.65 | 141.14 | |
| ROCE % | 8.71% | 7.37% | 5.26% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Net Capital Turnover Ratio ratio ・Standalone data |
|
|||
| Payables Turnover Ratio ratio ・Standalone data |
||||
| Receivables Turnover Ratio ratio ・Standalone data |
||||
| Number of Manufacturing Units count ・Standalone data |
||||
| Number of Permanent Employees count ・Standalone data |
||||
| Median Employee Remuneration INR ・Standalone data |
||||
Extracted by Screener AI
Documents
Announcements
-
Statement of deviation(s) or variation(s) under Reg. 32
29 May 2026 - No deviation in ₹2,056.8 lakh public issue proceeds as of 31 March 2026.
-
Utilisation of Funds
29 May 2026 - Half-year ended 31 Mar 2026 statement shows no deviation in Rs2,056.8 lakh public issue proceeds.
-
Outcome of Board Meeting
29 May 2026 - Board approved audited standalone and consolidated FY26 results on 29 May 2026; auditors gave unmodified opinion.
-
Structural Digital Database
11 May 2026 - FY2026 SDD compliance certificate filed; company captured 7 required UPSI events.
-
Disclosure under SEBI Takeover Regulations
8 May 2026 - Promoter disclosed 99,35,400 shares held as of March 31, 2026; no encumbrance during FY2026.
Business Overview:[1]
YCCL is a part of Yash Chemex Ltd. It is an ISO, CE & GMP Certified domestic manufacturer of premium dyestuffs, FMCG products, IMCG Products, etc. with production facilities located in the chemical industrial zone in Gujarat.